Found: 19
Select item for more details and to access through your institution.
COVID-19 and autoinflammatory diseases: prevalence and outcomes of infection and early experience of vaccination in patients on biologics.
- Published in:
- Rheumatology Advances in Practice, 2021, v. 5, n. 2, p. 1, doi. 10.1093/rap/rkab043
- By:
- Publication type:
- Article
Update on Biomarkers of Vasculopathy in Juvenile and Adult Myositis.
- Published in:
- Current Rheumatology Reports, 2022, v. 24, n. 7, p. 227, doi. 10.1007/s11926-022-01076-4
- By:
- Publication type:
- Article
Anti-tumour necrosis factor treatment for the prevention of ischaemic events in patients with deficiency of adenosine deaminase 2 (DADA2).
- Published in:
- Rheumatology, 2021, v. 60, n. 9, p. 4373, doi. 10.1093/rheumatology/keaa837
- By:
- Publication type:
- Article
Identification and prediction of novel classes of long-term disease trajectories for patients with juvenile dermatomyositis using growth mixture models.
- Published in:
- Rheumatology, 2021, v. 60, n. 4, p. 1891, doi. 10.1093/rheumatology/keaa497
- By:
- Publication type:
- Article
Management of severe hyperinflammation in the COVID-19 era: the role of the rheumatologist.
- Published in:
- Rheumatology, 2021, v. 60, n. 2, p. 911, doi. 10.1093/rheumatology/keaa652
- By:
- Publication type:
- Article
British kindred with dominant FMF associated with high incidence of AA amyloidosis caused by novel MEFV variant, and a review of the literature.
- Published in:
- Rheumatology, 2020, v. 59, n. 3, p. 554, doi. 10.1093/rheumatology/kez334
- By:
- Publication type:
- Article
R10 Predictors associated with secondary Raynaud's phenomenon in children.
- Published in:
- 2018
- By:
- Publication type:
- Abstract
Janus kinase 1/2 inhibition with baricitinib in the treatment of juvenile dermatomyositis.
- Published in:
- Brain: A Journal of Neurology, 2019, v. 142, n. 3, p. e8, doi. 10.1093/brain/awz005
- By:
- Publication type:
- Article
Janus kinase 1/2 inhibition with baricitinib in the treatment of juvenile dermatomyositis.
- Published in:
- 2019
- By:
- Publication type:
- letter
Mycophenolate Mofetil Versus Cyclophosphamide for Remission Induction in Childhood Polyarteritis Nodosa: An Open‐Label, Randomized, Bayesian Noninferiority Trial.
- Published in:
- Arthritis & Rheumatology, 2021, v. 73, n. 9, p. 1673, doi. 10.1002/art.41730
- By:
- Publication type:
- Article
The Vasculopathy of Juvenile Dermatomyositis: Endothelial Injury, Hypercoagulability, and Increased Arterial Stiffness.
- Published in:
- Arthritis & Rheumatology, 2021, v. 73, n. 7, p. 1253, doi. 10.1002/art.41639
- By:
- Publication type:
- Article
Treatment of Juvenile Dermatomyositis: An Update.
- Published in:
- Pediatric Drugs, 2017, v. 19, n. 5, p. 423, doi. 10.1007/s40272-017-0240-6
- By:
- Publication type:
- Article
JAK inhibitors: a potential treatment for JDM in the context of the role of interferon-driven pathology.
- Published in:
- Pediatric Rheumatology, 2021, v. 19, n. 1, p. 1, doi. 10.1186/s12969-021-00637-8
- By:
- Publication type:
- Article
Maternal smoking during pregnancy and risk for childhood leukemia: A nationwide case-control study in Greece and meta-analysis.
- Published in:
- Pediatric Blood & Cancer, 2012, v. 58, n. 3, p. 344, doi. 10.1002/pbc.23347
- By:
- Publication type:
- Article
Retrospective analysis of infliximab and adalimumab treatment in a large cohort of juvenile dermatomyositis patients.
- Published in:
- Arthritis Research & Therapy, 2020, v. 22, n. 1, p. 1, doi. 10.1186/s13075-020-02164-5
- By:
- Publication type:
- Article
Use of Rescue Therapy with IVIG or Cyclophosphamide in Juvenile Myositis.
- Published in:
- Current Rheumatology Reports, 2021, v. 23, n. 4, p. 1, doi. 10.1007/s11926-021-00990-3
- By:
- Publication type:
- Article
Treatment of Calcinosis in Juvenile Dermatomyositis.
- Published in:
- Current Rheumatology Reports, 2021, v. 23, n. 2, p. 1, doi. 10.1007/s11926-020-00974-9
- By:
- Publication type:
- Article
Pericarditis and Autoinflammation: A Clinical and Genetic Analysis of Patients With Idiopathic Recurrent Pericarditis and Monogenic Autoinflammatory Diseases at a National Referral Center.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Delineating the Role of Multiple Intraarticular Corticosteroid Injections in the Management of Juvenile Idiopathic Arthritis in the Biologic Era.
- Published in:
- Arthritis Care & Research, 2013, v. 65, n. 7, p. 1112, doi. 10.1002/acr.21947
- By:
- Publication type:
- Article